Medicare Enrolled

Dr. Nadeem Khan, M.D.

Infectious Disease · Tampa, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4729 N HABANA AVE, Tampa, FL 33614
8132518444
In practice since 2005 (20 years)
NPI: 1174506703 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khan

Dr. Nadeem Khan is an infectious disease in Tampa, FL, with 20 years in practice. Based on federal Medicare data, Dr. Khan performed 3,691 Medicare services across 1,191 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khan received a total of $14,666 from 40 pharmaceutical and/or device companies across 733 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 15% volume in FL$ $14,666 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,691
Medicare services
Top 15% in FL for infectious disease
1,191
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~185 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, moderate complexity2,063$63$216
Initial hospital admission, moderate complexity494$104$410
Injection, ertapenem sodium, 500 mg346$10$90
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less309$49$210
Office visit, established patient (20-29 min)145$67$273
Hospital follow-up visit, high complexity141$96$310
Office visit, established patient (10-19 min)65$34$165
Blood draw (venipuncture)63$8$15
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow45$79$371
New patient office visit (45-59 min)20$125$507
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.4% high complexity
9.4% medium
82.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,666
Total received (2018-2024)
Avg $2,095/year across 7 years
Top 11% in FL for infectious disease
40
Companies
733
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,349 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$317 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,744
2023
$2,862
2022
$2,279
2021
$2,018
2020
$982
2019
$1,958
2018
$1,823

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ViiV Healthcare Company
$2,359
Gilead Sciences, Inc.
$2,088
ABBVIE INC.
$1,270
Janssen Biotech, Inc.
$1,072
Insmed, Inc.
$907
Merck Sharp & Dohme Corporation
$844
Merck Sharp & Dohme LLC
$684
Melinta Therapeutics, LLC
$573
Astellas Pharma US Inc
$504
Shionogi Inc
$476
Melinta Therapeutics, Inc.
$420
Boehringer Ingelheim Pharmaceuticals, Inc.
$397
La Jolla Pharmaceutical Company
$364
Cumberland Pharmaceuticals, Inc.
$325
Paratek Pharmaceuticals, Inc.
$253
AstraZeneca Pharmaceuticals LP
$246
Boston Scientific Corporation
$238
Ferring Pharmaceuticals Inc.
$213
AbbVie Inc.
$157
AbbVie, Inc.
$155
BOSTON SCIENTIFIC CORPORATION
$154
Allergan Inc.
$124
Theratechnologies Inc.
$117
TETRAPHASE PHARMACEUTICALS, INC.
$109
Theravance Biopharma, Inc.
$82
AIMMUNE THERAPEUTICS, INC.
$77
Dynavax Technologies Corporation
$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$48
Genentech USA, Inc.
$48
Napo Pharmaceuticals Inc
$46
INSYS Therapeutics Inc
$41
Vyera Pharmaceuticals, LLC
$40
RedHill Biopharma Inc.
$27
Nabriva Therapeutics, plc
$26
Janssen Pharmaceuticals, Inc
$25
Hologic Sales and Service, LLC
$25
Alnylam Pharmaceuticals Inc.
$24
Smith+Nephew, Inc.
$22
Allergan, Inc.
$18
Shire North American Group Inc
$11
Top 3 companies account for 39.0% of total payments
Associated products mentioned in payments ›
APRETUDE · APTIMA · AVYCAZ · Arikayce · BEVESPI AEROSPHERE · Baxdela · CABENUVA · Cresemba · DALVANCE · DELSTRIGO · DIFICID · DOVATO · Daraprim Tablet 25mg · EGRIFTA · Fetroja · GATTEX · GIVLAARI · Heplisav-B · ISENTRESS · JULUCA · Kimyrsa · MAVYRET · Mavyret · Mytesi · NOXAFIL · NUZYRA · OFEV · Orbactiv · PICO · PIFELTRO · PREVYMIS · PREZCOBIX · REBYOTA · RECARBRIO · RUKOBIA · Rezzayo · SPEVIGO · SYMTUZA · SYNDROS · Symtuza · TEFLARO · TRIUMEQ · TROGARZO · Talicia · VIBATIV · VOWST · Vabomere · Veklury · Vibativ · WATCHMAN · WATCHMAN Access System · XARELTO · XERAVA · XIFAXAN · Xenleta · Xerava · Xofluza · ZERBAXA · ZINPLAVA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $397 per 100 Medicare services performed
Looking for a infectious disease in Tampa?
Compare infectious diseases in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious Diseases within 10 mi
94
Per 100K population
6.3
County median income
$75,011
Nearest hospital
AdventHealth Carrollwood
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Khan is a mixed practice specialist, with above-average Medicare volume (top 15% in FL), and high industry engagement (low-engagement, top 11%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Khan experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Khan performed 2,063 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $14,666 from 40 companies across 733 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other infectious diseases in Tampa?
Dr. Khan's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →